Lixia He, PhD

After graduating from Peking University in 2016, I joined the Dr. George Blackburn Lab at Beth Israel Deaconess Medical Center, Harvard Medical School, as a postdoctoral fellow. 

In 2019, I joined the Kaelin Lab at Dana-Farber Cancer Institute as a Research Lab Manager and hold an appointment as a Research Associate at Harvard Medical School. 

Currently, as a Research Scientist II, I investigate the effects of EGLNs and FIH1 inhibition on the regulation of erythropoietin and vascular endothelial growth factor.